FLGT FY 2019 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

FY 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$33M+52.3% YoY

Gross Profit

$18M56.6% margin

Operating Income

-$428,000-1.3% margin

Net Income

-$411,000-1.3% margin

EPS (Diluted)

$-0.02

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$89M

Total Liabilities

$6M

Stockholders' Equity

$83M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$21M	+52.3%
Gross Profit	$18M	$11M	+72.7%
Operating Income	-$428,000	-$5M	+91.6%
Net Income	-$411,000	-$6M	+92.7%